_version_ 1785091134787158016
author Sarkozy, Clementine
Thieblemont, Catherine
Oberic, Lucie
Moreau, Anne
Bouabdallah, Kamal
Laurent Damaj, Gandhi
Gastinne, Thomas
Ribrag, Vincent
Olivier Casasnovas, Rene
Haioun, Corinne
Houot, Roch
Jardin, Fabrice
Neste, Eric Van Den
Cheminant, Morgane
Morschhauser, Franck
Callanan, Mary
Ghesquieres, Herve
Gressin, Remy
Hermine, Olivier
Le Gouill, Steven
author_facet Sarkozy, Clementine
Thieblemont, Catherine
Oberic, Lucie
Moreau, Anne
Bouabdallah, Kamal
Laurent Damaj, Gandhi
Gastinne, Thomas
Ribrag, Vincent
Olivier Casasnovas, Rene
Haioun, Corinne
Houot, Roch
Jardin, Fabrice
Neste, Eric Van Den
Cheminant, Morgane
Morschhauser, Franck
Callanan, Mary
Ghesquieres, Herve
Gressin, Remy
Hermine, Olivier
Le Gouill, Steven
author_sort Sarkozy, Clementine
collection PubMed
description
format Online
Article
Text
id pubmed-10431158
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104311582023-08-17 P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY. Sarkozy, Clementine Thieblemont, Catherine Oberic, Lucie Moreau, Anne Bouabdallah, Kamal Laurent Damaj, Gandhi Gastinne, Thomas Ribrag, Vincent Olivier Casasnovas, Rene Haioun, Corinne Houot, Roch Jardin, Fabrice Neste, Eric Van Den Cheminant, Morgane Morschhauser, Franck Callanan, Mary Ghesquieres, Herve Gressin, Remy Hermine, Olivier Le Gouill, Steven Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431158/ http://dx.doi.org/10.1097/01.HS9.0000971212.06197.a0 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Sarkozy, Clementine
Thieblemont, Catherine
Oberic, Lucie
Moreau, Anne
Bouabdallah, Kamal
Laurent Damaj, Gandhi
Gastinne, Thomas
Ribrag, Vincent
Olivier Casasnovas, Rene
Haioun, Corinne
Houot, Roch
Jardin, Fabrice
Neste, Eric Van Den
Cheminant, Morgane
Morschhauser, Franck
Callanan, Mary
Ghesquieres, Herve
Gressin, Remy
Hermine, Olivier
Le Gouill, Steven
P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
title P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
title_full P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
title_fullStr P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
title_full_unstemmed P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
title_short P1079: VERY LONG-TERM FOLLOW-UP OF RITUXIMAB MAINTENANCE IN YOUNG PATIENTS WITH MANTLE CELL LYMPHOMA INCLUDED IN THE LYMA TRIAL, A LYSA STUDY.
title_sort p1079: very long-term follow-up of rituximab maintenance in young patients with mantle cell lymphoma included in the lyma trial, a lysa study.
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431158/
http://dx.doi.org/10.1097/01.HS9.0000971212.06197.a0
work_keys_str_mv AT sarkozyclementine p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT thieblemontcatherine p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT obericlucie p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT moreauanne p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT bouabdallahkamal p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT laurentdamajgandhi p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT gastinnethomas p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT ribragvincent p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT oliviercasasnovasrene p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT haiouncorinne p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT houotroch p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT jardinfabrice p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT nesteericvanden p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT cheminantmorgane p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT morschhauserfranck p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT callananmary p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT ghesquieresherve p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT gressinremy p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT hermineolivier p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy
AT legouillsteven p1079verylongtermfollowupofrituximabmaintenanceinyoungpatientswithmantlecelllymphomaincludedinthelymatrialalysastudy